Zihao Tang

Zihao Tang

Auto-generated profile, based on publicly available information

Zihao Tang

University of Sydney

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2023 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
MBMichael Barnett
Michael Barnett
DWDongang Wang
Dongang Wang
HBHeidi Beadnall
Heidi Beadnall
ABAntje Bischof
Antje Bischof
DBDavid Brunacci
David Brunacci
CWChenyu Wang
Chenyu Wang
Modern management of MS targets No Evidence of Disease Activity (NEDA): no clinical relapses, no magnetic resonance imaging (MRI) disease activity and no disability worsening. While MRI is the principal tool available to neurologists for monitoring clinically silent MS disease activity and, where appropriate, escalating treatment, standard radiology reports are qualitative and may be insensitive to the development of new or enlarging lesions. Existing quantitative neuroimaging tools lack adequate clinical validation. In 397 multi-center MRI scan pairs acquired in routine practice, we demonstrate superior case-level sensitivity of a clinically integrated AI-based tool over standard radiology reports (93.3% vs 58.3%), relative to a consensus ground truth, with minimal loss of specificity. We also demonstrate equivalence of the AI-tool with a core clinical trial imaging lab for lesion activity and quantitative brain volumetric measures, including percentage brain volume loss (PBVC), an accepted biomarker of neurodegeneration in MS (mean PBVC −0.32% vs −0.36%, respectively), whereas even severe atrophy (>0.8% loss) was not appreciated in radiology reports. Finally, the AI-tool additionally embeds a clinically meaningful, experiential comparator that returns a relevant MS patient centile for lesion burden, revealing, in our cohort, inconsistencies in qualitative descriptors used in radiology reports. AI-based image quantitation enhances the accuracy of, and value-adds to, qualitative radiology reporting. Scaled deployment of these tools will open a path to precision management for patients with MS.

16 February 2022 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
YMYang Ma
Yang Ma
CZChaoyi Zhang
Chaoyi Zhang
MCMariano Cabezas
Mariano Cabezas
YSYang Song
Yang Song
ZTZihao Tang
Zihao Tang
CWChenyu Wang
Chenyu Wang
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system, characterized by the appearance of focal lesions in the white and gray matter that topographically correlate with an individual patient’s neurological symptoms and signs. Magnetic resonance imaging (MRI) provides detailed in-vivo structural information, permitting the quantification and categorization of MS lesions that critically inform disease management. Traditionally, MS lesions have been manually annotated on 2D MRI slices, a process that is inefficient and prone to inter-/intra-observer errors. Recently, automated statistical imaging analysis techniques have been proposed to detect and segment MS lesions based on MRI voxel intensity. However, their effectiveness is limited by the heterogeneity of both MRI data acquisition techniques and the appearance of MS lesions. By learning complex lesion representations directly from images, deep learning techniques have achieved remarkable breakthroughs in the MS lesion segmentation task. Here, we provide a comprehensive review of state-of-the-art automatic statistical and deep-learning MS segmentation methods and discuss current and future clinical applications. Further, we review technical strategies, such as domain adaptation, to enhance MS lesion segmentation in real-world clinical settings.

28 July 2023 in NeuroImage: Clinical
Verified
Journal Article
Open access
SASantiago Aja-Fernández
Santiago Aja-Fernández
CMCarmen Martín-Martín
Carmen Martín-Martín
ÁPÁlvaro Planchuelo-Gómez
Álvaro Planchuelo-Gómez
AFABRAR FAIYAZ
ABRAR FAIYAZ
NUNasir Uddin
Nasir Uddin
TPTomasz Pieciak
Tomasz Pieciak
The objective of this study is to evaluate the efficacy of deep learning (DL) techniques in improving the quality of diffusion MRI (dMRI) data in clinical applications. The study aims to determine whether the use of artificial intelligence (AI) methods in medical images may result in the loss of critical clinical information and/or the appearance of false information. To assess this, the focus was on the angular resolution of dMRI and a clinical trial was conducted on migraine, specifically between episodic and chronic migraine patients. The number of gradient directions had an impact on white matter analysis results, with statistically significant differences between groups being drastically reduced when using 21 gradient directions instead of the original 61. Fourteen teams from different institutions were tasked to use DL to enhance three diffusion metrics (FA, AD and MD) calculated from data acquired with 21 gradient directions and a b-value of 1000 s/mm2. The goal was to produce results that were comparable to those calculated from 61 gradient directions. The results were evaluated using both standard image quality metrics and Tract-Based Spatial Statistics (TBSS) to compare episodic and chronic migraine patients. The study results suggest that while most DL techniques improved the ability to detect statistical differences between groups, they also led to an increase in false positive. The results showed that there was a constant growth rate of false positives linearly proportional to the new true positives, which highlights the risk of generalization of AI-based tasks when assessing diverse clinical cohorts and training using data from a single group. The methods also showed divergent performance when replicating the original distribution of the data and some exhibited significant bias. In conclusion, extreme caution should be exercised when using AI methods for harmonization or synthesis in clinical studies when processing heterogeneous data in clinical studies, as important information may be altered, even when global metrics such as structural similarity or peak signal-to-noise ratio appear to suggest otherwise.

21 September 2021
Verified
Book Chapter
Closed access
PDF file
ZTZihao Tang
Zihao Tang
MCMariano Cabezas
Mariano Cabezas
DLDongnan Liu
Dongnan Liu
MBMichael Barnett
Michael Barnett
WCWeidong Cai
Weidong Cai
CWChenyu Wang
Chenyu Wang

1 December 2022
Verified
Book Chapter
Closed access
PDF file
ZTZihao Tang
Zihao Tang
XWXinyi Wang
Xinyi Wang
MCMariano Cabezas
Mariano Cabezas
ADArkiev D’sOuza
Arkiev D’sOuza
FCFernando Calamante
Fernando Calamante
WCWeidong Cai
Weidong Cai